These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 19448113)

  • 21. Differentiation of renal cell carcinoma subtypes through MRI-based radiomics analysis.
    Wang W; Cao K; Jin S; Zhu X; Ding J; Peng W
    Eur Radiol; 2020 Oct; 30(10):5738-5747. PubMed ID: 32367419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
    Velickovic M; Delahunt B; Störkel S; Grebem SK
    Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Papillary vs clear cell renal cell carcinoma. Differentiation and grading by iodine concentration using DECT-correlation with microvascular density.
    Marcon J; Graser A; Horst D; Casuscelli J; Spek A; Stief CG; Reiser MF; Rübenthaler J; Buchner A; Staehler M
    Eur Radiol; 2020 Jan; 30(1):1-10. PubMed ID: 31278580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Papillary renal cell carcinoma in contrast-enhanced ultrasound (CEUS) - A diagnostic performance study.
    Mueller-Peltzer K; Negrao de Figueiredo G; Graf T; Rübenthaler J; Clevert DA
    Clin Hemorheol Microcirc; 2019; 71(2):159-164. PubMed ID: 30562896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low enhancing papillary renal cell carcinoma diagnosed by using dual energy computerized tomography: a case report and review of literature.
    Alanee S; Dynda DI; Hemmer P; Schwartz B
    BMC Urol; 2014 Dec; 14():102. PubMed ID: 25524502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ipsilateral adrenalectomy is not obligatory in nephrectomy for renal cell carcinoma].
    Aliaev IuG; Akhvlediani ND; Blokhin PS
    Urologiia; 2008; (2):16-22. PubMed ID: 18574876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Differentiation of subtypes of renal cell carcinoma by double-phase helical computed tomography].
    Dai JR; Zhang LY; Zhang J; Chen Y; Zhang HT; Jiang LX; Lin M
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(31):2177-81. PubMed ID: 21029656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases.
    Marsaud A; Dadone B; Ambrosetti D; Baudoin C; Chamorey E; Rouleau E; Lefol C; Roussel JF; Fabas T; Cristofari G; Carpentier X; Michiels JF; Amiel J; Pedeutour F
    Genes Chromosomes Cancer; 2015 Jun; 54(6):369-82. PubMed ID: 25820192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of radiologic tumor volume and pathologic tumor volume in renal cell carcinoma (RCC).
    Choi SM; Choi DK; Kim TH; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
    PLoS One; 2015; 10(3):e0122019. PubMed ID: 25799553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transitional cell and clear cell renal carcinoma: differentiation of distinct histological types with multiphase CT.
    Bata P; Tarnoki DL; Tarnoki AD; Novak PK; Gyebnar J; Kekesi D; Szendroi A; Fejer B; Szasz AM; Nyirady P; Karlinger K; Berczi V
    Acta Radiol; 2014 Nov; 55(9):1112-9. PubMed ID: 24243889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of CT, MRI imaging features of renal cell carcinoma with different histopathological types.
    Wang X; Kong W; Wang Y; Wang Y; Chen Y; Shi Z; Liu Y
    J BUON; 2021; 26(5):2053-2058. PubMed ID: 34761616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease.
    Wagener N; Edelmann D; Benner A; Zigeuner R; Borgmann H; Wolff I; Krabbe LM; Musquera M; Dell'Oglio P; Capitanio U; Klatte T; Cindolo L; May M; Brookman-May SD;
    PLoS One; 2017; 12(9):e0184173. PubMed ID: 28934212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromophobe renal cell carcinoma in Iceland: an epidemiological and clinicopathological study.
    Ingimarsson JP; Hardarson S; Petursdottir V; Jonsson E; Einarsson GV; Gudbjartsson T
    Scand J Urol Nephrol; 2011 Nov; 45(5):306-11. PubMed ID: 21619417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinico-radio-pathologic features of a solitary solid renal mass at MDCT examination.
    Kim EY; Park BK; Kim CK; Lee HM
    Acta Radiol; 2010 Dec; 51(10):1143-8. PubMed ID: 20849320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumours in end-stage kidney.
    Hora M; Hes O; Reischig T; Urge T; Klecka J; Ferda J; Michal M; Eret V
    Transplant Proc; 2008 Dec; 40(10):3354-8. PubMed ID: 19100388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential diagnosis of chromophobe renal cell carcinoma and papillary renal cell carcinoma with dual-energy spectral computed tomography.
    Wang D; Huang X; Bai L; Zhang X; Wei J; Zhou J
    Acta Radiol; 2020 Nov; 61(11):1562-1569. PubMed ID: 32088966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rupture of papillary renal cell carcinoma.
    Hora M; Hes O; Klecka J; Boudová L; Chudácek Z; Kreuzberg B; Michal M
    Scand J Urol Nephrol; 2004; 38(6):481-4. PubMed ID: 15841782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative analysis of modern combined methods in diagnosis of renal cell carcinoma].
    Teodorovich OV; Ternovoĭ SK; Vlasova IS; Zabrodina NB; Fominykh EV; Kesov IaE
    Urologiia; 2006; (5):3-6, 11. PubMed ID: 17444144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicentric papillary and chromophobe renal cell carcinomas in a patient with autosomal dominant polycystic kidney disease: Report of a rare case.
    Sahoo N; Patra S; Senapati S; Mishra TS
    Indian J Pathol Microbiol; 2017; 60(3):405-408. PubMed ID: 28937383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Radiologic diagnosis as a component of staging and surgical approach in carcinoma of the renal parenchyma].
    Kaprin AD; Khudiashev SA; Shchetinin VV
    Vopr Onkol; 2009; 55(5):594-7. PubMed ID: 20020655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.